Home » Psychology news » Renewed hope for treatment of pain and depression
Renewed hope for treatment of pain and depression
June 19, 2020 by NewsBot
Researchers have developed LIH383, a novel molecule that binds to and blocks a previously unknown opioid receptor in the brain, thereby modulating the levels of opioid peptides produced in the central nervous system (CNS) and potentiating their natural painkilling and antidepressant properties.